Concepedia

Advantageous Solubility-Permeability Interplay When Using Amorphous Solid Dispersion (ASD) Formulation for the BCS Class IV P-gp Substrate Rifaximin: Simultaneous Increase of Both the Solubility and the Permeability

Avital Beig, Noa Fine‐Shamir, David Lindley, Jonathan M. Miller, Arik Dahan

The AAPS Journal · 2017 · 59 citations · 38 references

DOIFull text

Open access

Concepts

References

38

A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability

Gordon L. Amidon, Hans Lennernäs, Vinod P. Shah et al. · Pharmaceutical Research · 1995 · 5.3K citations · Full text

BDDCS Applied to Over 900 Drugs

Leslie Z. Benet, Fabio Broccatelli, Tudor I. Oprea · The AAPS Journal · 2011 · 613 citations · Full text

, , +5

Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis

Sharad B. Murdande, Michael J. Pikal, Ravi Shanker et al. · Journal of Pharmaceutical Sciences · 2009 · 382 citations

, , +5

A Win–Win Solution in Oral Delivery of Lipophilic Drugs: Supersaturation via Amorphous Solid Dispersions Increases Apparent Solubility without Sacrifice of Intestinal Membrane Permeability

Jonathan M. Miller, Avital Beig, Robert A. Carr et al. · Molecular Pharmaceutics · 2012 · 250 citations

The Solubility–Permeability Interplay in Using Cyclodextrins as Pharmaceutical Solubilizers: Mechanistic Modeling and Application to Progesterone

Arik Dahan, Jonathan M. Miller, Amnon Hoffman et al. · Journal of Pharmaceutical Sciences · 2009 · 220 citations · Full text

, , +11